The global community is facing a number of urgent challenges, such as emerging diseases, epidemics, antimicrobial resistance, ...

Data from Catalent’s preclinical studies evaluating certepetide as a SMARTag® ADC payload showed both improved tumor selective penetration and efficacy BASKING RIDGE, N.J., Nov. 04, 2025 (GLOBE ...

The surge in AI and digital infrastructure is making data centers the fastest-growing source of new electricity demand in ...

ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy® (epinephrine nasal spray) ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...

Explore NotebookLM's new features, including deep research mode and data tables, designed to simplify research and improve ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

In this episode of "Uncanny Valley," we discuss the economics and environmental impacts of energy-hungry data centers and ...

Vitamin D2 supplements may negatively impact circulating levels of vitamin D3 and negate the latter's potential benefits, ...

An Amazon Web Services data center situated near single-family homes in Stone Ridge, Virginia (Nathan Howard/Getty Images) Data centers are creating problems for the congested, overburdened U.S. power ...

Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to be presented as a late-breaking oral ...

New data from telisotuzumab adizutecan (Temab-A) and ABBV-706 across pancreatic, colorectal, and solid tumors, highlight progress in AbbVie's growing ADC portfolio designed to target ...